Form D · Biotechnology
Bullet Biotechnology, Inc.
Redwood City, CA · CIK 0001539978
Offering snapshot reported Jun 29, 2016 · SEC filing
- Reported sold
- $344K Offering amount: $1.44M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 21, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2016 | Initial | $343,995 | No comparison | 13 | SEC filing |
| Mar 24, 2015 | Initial | $699,834 | No comparison | 17 | SEC filing |
| Jul 9, 2013 | Initial | $1,135,198 | No comparison | 34 | SEC filing |
| Feb 8, 2012 | Initial | $565,305 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-265977
Source: Form D, filed Jun 29, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Diego Fonstad | Director |
| William P. Quinn | Director, Executive |
| Mark Robbins | Executive |
| Samuel Saks | Director |
| Glen Sato | Executive |
| Jay Shepard | Director |
| James R. Swartz | Director |
| Thomas P. Theriault | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2686 Middlefield Road, Suite D
Redwood City, CA, 94063
Redwood City, CA, 94063